ArticleThrombosis and haemostasis2022

Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT Study.

Isabelle Mahé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.